Home » Topics » BioWorld

BioWorld
RSS

CYGNUS POSTPONES STOCK SALE

April 21, 1992

LIGAND READIES ITS IPO

April 21, 1992

GRANT TO STUDY NERVE DEATH GENES

April 21, 1992

NOVA FILES FOR PERGAMID APPROVAL

April 21, 1992

STOCK SKID SEEMS RELENTLESS

April 21, 1992

FDA PANEL AFFIRMS DDI DECISION

April 21, 1992

APPOINTMENTS AND ADVANCEMENTS

April 20, 1992

TARGETECH PATENT FOR LIVER GENE THERAPY

April 20, 1992

AMBICIN KILLS ULCERATING BACTERIUM

April 20, 1992

MICROPROBE SBIR FOR ANTI-GENE DELIVERY

April 20, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...